185 related articles for article (PubMed ID: 28430599)
1. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis.
Guan S; Lu J; Zhao Y; Woodfield SE; Zhang H; Xu X; Yu Y; Zhao J; Bieerkehazhi S; Liang H; Yang J; Zhang F; Sun S
Oncotarget; 2017 May; 8(20):33666-33675. PubMed ID: 28430599
[TBL] [Abstract][Full Text] [Related]
2. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy.
Fan Y; Cheng J; Vasudevan SA; Patel RH; Liang L; Xu X; Zhao Y; Jia W; Lu F; Zhang H; Nuchtern JG; Kim ES; Yang J
Apoptosis; 2013 Oct; 18(10):1224-34. PubMed ID: 23700229
[TBL] [Abstract][Full Text] [Related]
3. Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line Daudi.
Zhang J; Li B; Wu H; Ou J; Wei R; Liu J; Cai W; Liu X; Zhao S; Yang J; Zhou L; Liu S; Liang A
Tumour Biol; 2016 Jan; 37(1):531-9. PubMed ID: 26227222
[TBL] [Abstract][Full Text] [Related]
4. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol.
Wu J; Powell F; Larsen NA; Lai Z; Byth KF; Read J; Gu RF; Roth M; Toader D; Saeh JC; Chen H
ACS Chem Biol; 2013 Mar; 8(3):643-50. PubMed ID: 23272696
[TBL] [Abstract][Full Text] [Related]
5. TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage.
Zhang D; Yan H; Li H; Hao S; Zhuang Z; Liu M; Sun Q; Yang Y; Zhou M; Li K; Hang C
J Biol Chem; 2015 Aug; 290(32):19900-9. PubMed ID: 26100626
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of hyperthermia-induced apoptosis by 5Z-7-oxozeaenol, a TAK1 inhibitor, in A549 cells.
Li P; Zhao QL; Jawaid P; Rehman MU; Sakurai H; Kondo T
Cell Stress Chaperones; 2016 Sep; 21(5):873-81. PubMed ID: 27448221
[TBL] [Abstract][Full Text] [Related]
7. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ
Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584
[TBL] [Abstract][Full Text] [Related]
8. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase.
Ninomiya-Tsuji J; Kajino T; Ono K; Ohtomo T; Matsumoto M; Shiina M; Mihara M; Tsuchiya M; Matsumoto K
J Biol Chem; 2003 May; 278(20):18485-90. PubMed ID: 12624112
[TBL] [Abstract][Full Text] [Related]
9. TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells.
Wang Z; Zhang H; Shi M; Yu Y; Wang H; Cao WM; Zhao Y; Zhang H
Sci Rep; 2016 Sep; 6():32737. PubMed ID: 27599572
[TBL] [Abstract][Full Text] [Related]
10. Effects of (5Z)-7-oxozeaenol on MDA-MB-231 breast cancer cells.
Acuña UM; Wittwer J; Ayers S; Pearce CJ; Oberlies NH; DE Blanco EJ
Anticancer Res; 2012 Jul; 32(7):2415-21. PubMed ID: 22753698
[TBL] [Abstract][Full Text] [Related]
11. Blockade of transforming growth factor-beta-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade.
Choo MK; Kawasaki N; Singhirunnusorn P; Koizumi K; Sato S; Akira S; Saiki I; Sakurai H
Mol Cancer Ther; 2006 Dec; 5(12):2970-6. PubMed ID: 17172402
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor β-activated kinase 1 inhibitor suppresses the proliferation in triple-negative breast cancer through TGF-β/TGFR pathway.
Zhang L; Fu Z; Li X; Tang H; Luo J; Zhang D; Zhuang Y; Han Z; Yin M
Chem Biol Drug Des; 2017 Sep; 90(3):450-455. PubMed ID: 28224764
[TBL] [Abstract][Full Text] [Related]
13. Effects of (5Z)-7-oxozeaenol on the oxidative pathway of cancer cells.
Acuña UM; Wittwer J; Ayers S; Pearce CJ; Oberlies NH; DE Blanco EJ
Anticancer Res; 2012 Jul; 32(7):2665-71. PubMed ID: 22753724
[TBL] [Abstract][Full Text] [Related]
14. TAK1 ubiquitination regulates doxorubicin-induced NF-κB activation.
Liang L; Fan Y; Cheng J; Cheng D; Zhao Y; Cao B; Ma L; An L; Jia W; Su X; Yang J; Zhang H
Cell Signal; 2013 Jan; 25(1):247-54. PubMed ID: 22981905
[TBL] [Abstract][Full Text] [Related]
15. IL-17F induces IL-6 via TAK1-NFκB pathway in airway smooth muscle cells.
Nakajima M; Kawaguchi M; Ota K; Fujita J; Matsukura S; Huang SK; Morishima Y; Ishii Y; Satoh H; Sakamoto T; Hizawa N
Immun Inflamm Dis; 2017 Jun; 5(2):124-131. PubMed ID: 28474507
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of transforming growth factor-β-activated kinase 1 promotes taxol efficacy in ovarian cancer cells.
Bo L; Cui H; Fang Z; Qun T; Xia C
Biomed Pharmacother; 2016 Dec; 84():917-924. PubMed ID: 27764753
[TBL] [Abstract][Full Text] [Related]
17. Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization.
Wang JH; Tseng CL; Lin FL; Chen J; Hsieh EH; Lama S; Chuang YF; Kumar S; Zhu L; McGuinness MB; Hernandez J; Tu L; Wang PY; Liu GS
Theranostics; 2022; 12(2):657-674. PubMed ID: 34976206
[No Abstract] [Full Text] [Related]
18. Blockade of TGF-β-activated kinase 1 prevents advanced glycation end products-induced inflammatory response in macrophages.
Xu X; Qi X; Shao Y; Li Y; Fu X; Feng S; Wu Y
Cytokine; 2016 Feb; 78():62-8. PubMed ID: 26687627
[TBL] [Abstract][Full Text] [Related]
19. TAK1 signaling activity links the mast cell cytokine response and degranulation in allergic inflammation.
Watson CJF; Maguire ARR; Rouillard MM; Crozier RWE; Yousef M; Bruton KM; Fajardo VA; MacNeil AJ
J Leukoc Biol; 2020 Apr; 107(4):649-661. PubMed ID: 32108376
[TBL] [Abstract][Full Text] [Related]
20. Protection from cerebral ischemia by inhibition of TGFβ-activated kinase.
White BJ; Tarabishy S; Venna VR; Manwani B; Benashski S; McCullough LD; Li J
Exp Neurol; 2012 Sep; 237(1):238-45. PubMed ID: 22683931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
